One-year, single-center cost analysis of mycophenolate mofetil versus azathioprine following cadaveric renal transplantation

By Khosla U.M.   Martin J.E.   Baker G.M.   Schroeder T.J.   First M.R.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 274-275

Elsevier

Access to resources Recommend Favorite

The replacement of azathioprine by mycophenolate mofetil in pediatric patients with specific risks in renal transplantation

By Anguita A.   Repetto H.A.   Rodriguez-Rilo L.   Vazquez L.A.   Iturzaeta A.   Morrone G.   Deheza R.   Maldonado L.   Goldberg J.L.  

Transplantation Proceedings, Vol. 31, Iss. 6, 1999-09 ,pp. : 2279-2279

Elsevier

Access to resources Recommend Favorite

Simultaneous Pancreas/Kidney Transplantation: Comparison of Mycophenolate Mofetil Versus Azathioprine

By Elkhammas E.A.   Yilmaz S.   Henry M.L.   Yenchar J.   Bumgardner G.L.   Pelletier R.P.   Ferguson R.M.  

Transplantation Proceedings, Vol. 30, Iss. 2, 1998-03 ,pp. : 512-512

Elsevier

Access to resources Recommend Favorite

The treatment of chronic rejection with mycophenolate mofetil versus azathioprine in kidney transplantation

By Jirasiritham S.   Sumethkul V.   Mavichak V.   Chalermsanyakorn P.  

Transplantation Proceedings, Vol. 32, Iss. 7, 2000-11 ,pp. : 2040-2042

Elsevier

Access to resources Recommend Favorite

Postmarketing evaluation of mycophenolate mofetil-based triple therapy immunosuppression compared with a conventional azathioprine-based regimen reveals enhanced efficacy and early pharmacoeconomic benefit after renal transplantation

By Wuthrich R.P.   Weinreich T.   Schwarzkopf A.K.   Candinas D.   Binswanger U.  

Transplantation Proceedings, Vol. 30, Iss. 8, 1998-12 ,pp. : 4096-4097

Elsevier

Access to resources Recommend Favorite